BNP Paribas Financial Markets’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $273K | Sell |
|
|||||
|
2023
Q4 | $190K | Buy |
|
|||||
|
2023
Q3 | $92.7K | Buy |
|
|||||
|
2023
Q2 | $104K | Sell |
|
|||||
|
2023
Q1 | $171K | Buy |
|
|||||
|
2022
Q4 | $141K | Buy |
|
|||||
|
2022
Q3 | $224K | Buy |
|
|||||
|
2022
Q2 | $193K | Sell |
|
|||||
|
2022
Q1 | $336K | Sell |
|
|||||
|
2021
Q4 | $475K | Buy |
|
|||||
|
2021
Q3 | $161K | Buy |
|
|||||
|
2021
Q2 | $65.4K | Sell |
|
|||||
|
2021
Q1 | $99.8K | Sell |
|
|||||
|
2020
Q4 | $138K | Sell |
|
|||||
|
2020
Q3 | $99.7K | Buy |
|
|||||
|
2020
Q2 | $22.3K | Sell |
|
|||||
|
2020
Q1 | $93K | Buy |
|
|||||
|
2019
Q4 | $52.5K | Buy |
|
|||||
|
2019
Q3 | $4.53K | Buy |
|
|||||
|
2019
Q2 | $468 | Buy |
|